Stephen Frytak
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Epidemiology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 2%
- Co-authors
- Edward T. CreaganCharles G. MoertelEvanthia GalanisJoseph RubinDavid L. AhmannJudith R. OʼFallonMichael J. O’ConnellEagan Rt
- Topics
- Lung Cancer Research Studies (42 papers)Lung Cancer Treatments and Mutations (32 papers)Neuroendocrine Tumor Research Advances (20 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Stephen Frytak
111 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.4k
- Epidemiology 637
- Molecular Biology 627
- Pathology and Forensic Medicine 493
Countries citing papers authored by Stephen Frytak
This map shows the geographic impact of Stephen Frytak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Frytak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Frytak more than expected).
Fields of papers citing papers by Stephen Frytak
This network shows the impact of papers produced by Stephen Frytak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Frytak. The network helps show where Stephen Frytak may publish in the future.
Co-authorship network of co-authors of Stephen Frytak
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Frytak. A scholar is included among the top collaborators of Stephen Frytak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Frytak. Stephen Frytak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 35 | |
| 3 | 18 | |
| 4 | 15 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 61 | |
| 8 | 6 | |
| 9 | 401 | |
| 10 | 17 | |
| 11 | 4 | |
| 12 | 8 | |
| 13 | 27 | |
| 14 | 6 | |
| 15 | 13 | |
| 16 | Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer. | 24 |
| 17 | Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung. | 18 |
| 18 | VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung. | 42 |
| 19 | Evaluation of a fixed alternating treatment in patients with advanced breast cancer. | 9 |
| 20 | Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer. | 79 |
About Stephen Frytak
Stephen Frytak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 113 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (42 papers), Lung Cancer Treatments and Mutations (32 papers) and Neuroendocrine Tumor Research Advances (20 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Pathology and Forensic Medicine (493 citations). Stephen Frytak has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Edward T. Creagan, Charles G. Moertel, Evanthia Galanis, Joseph Rubin, David L. Ahmann, Judith R. OʼFallon, Michael J. O’Connell, Eagan Rt, Allan J. Schutt and J H Edmonson. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.